Education
About Us
Working with TipRanks
Follow Us
Benjamin Looker Insider Profile
4 Followers
Benjamin Looker, General Counsel at Trillium Therapeutics, holds ― shares in Trillium Therapeutics (Ticker: TRIL), holds 183.66K shares in Esperion (Ticker: ESPR). Most recently, Benjamin Looker ― shares of Trillium Therapeutics on ― for an estimated value of ―.
Benjamin Looker Trillium Therapeutics (TRIL)General Counsel
Trillium Therapeutics (TRIL)
General Counsel
Ranked #45,168 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+9.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Benjamin Looker's holdings
Insider Roles
GC
Roles that Benjamin Looker holds in companies
Most Profitable Insider Trade
The most profitable trade made by Benjamin Looker
Benjamin Looker's Trading History
Trillium Therapeutics
―
―
―
―
Esperion
Mar 15, 2024
GC
Uninformative Buy
―
$310.39K
List of latest transactions for each holding click on a transaction to see Benjamin Looker's performance on stock
You May Also Like
Benjamin Looker insider profile FAQ
What is the percentage of profitable transactions made by Benjamin Looker?
The percentage of profitable transactions made by Benjamin Looker is 50%.
What is the average return per transaction made by Benjamin Looker?
The average return per transaction made by Benjamin Looker is 9.10%.
What stocks does Benjamin Looker hold?
Benjamin Looker holds: TRIL, ESPR stocks.
What was Benjamin Looker’s latest transaction?
Benjamin Looker latest transaction was an Uninformative Buy of ―.
What was Benjamin Looker's most profitable transaction?
Benjamin Looker’s most profitable transaction was an Informative Sell of ESPR stock on January 19, 2023. The return on the trade was 70.50%.
What is Benjamin Looker's role in Trillium Therapeutics?
Benjamin Looker's role in Trillium Therapeutics is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.